Risk Factors for PoorAutologous Peripheral blood Stem Cell Mobilization among Lymphoproliferative Disease Patients

Authors

  • Mohd Nazri Hassan Department of Haematology, School of medical Sciences, Health Campus, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia
  • Azlan Husin Hospital USM, Health Campus, USM, 16150 Kubang Kerian, Kelantan, Malaysia & Department of Medicine, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia
  • Rapiaah Mustaffa Department of Haematology, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia & Hospital USM, Health Campus, USM, 16150 Kubang Kerian, Kelantan, Malaysia
  • Rosline Hassan Department of Haematology, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia & Hospital USM, Health Campus, USM, 16150 Kubang Kerian, Kelantan, Malaysia
  • Mohd Ismail Ibrahim Department of Medicine, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia
  • Abu Dzarr Abdullah Hospital USM, Health Campus, USM, 16150 Kubang Kerian, Kelantan, Malaysia & Department of Medicine, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia
  • Noor Haslina Mohd Noor Department of Haematology, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia & Hospital USM, Health Campus, USM, 16150 Kubang Kerian, Kelantan, Malaysia

DOI:

https://doi.org/10.3329/bjms.v19i3.45863

Keywords:

autologous transplantation; stem cell mobilization; multiple myeloma; lymphoma

Abstract

Objective: Autologous peripheral blood haemopoietic stem cell (PBSC) transplantation is a standard therapeutic option for eligible patients with lymphoproliferative disease (LPD). The prerequisite for autologous PBSC transplantation is the successful stem cell mobilization. This study is aimed to determine the factors associated with poor PBSC mobilization in LPD patient at our center.

Materials and methods: This retrospective record review involved 39 multiple myeloma (MM) and 92 of lymphoma patients who had undergone PBSC mobilization from January 2009 until December 2016. Patients were mobilized with combination chemotherapy and granulocyte colony stimulating factor. Factors affecting mobilization including patient’s, disease and treatment characteristics werestudied.

Results: Majority of patients were Malay (93.9%) with the mean age at mobilization of 41.4 years. The mean of CD34+ cell dosage was 9.6x106 cells/kg. Successful and poor mobilization was found to be 90.8% and 9.2% respectively. Multivariate analysis showed that the significant risk factors for poor mobilization were age of ≥ 60 years (adjusted OR=38.43, p=0.005) and PB CD34+ cell count, <20 cells/uL (adjusted OR=132.69, p<0.001).

Conclusion:PB CD34+ cell count and age ≥ 60years were the main risk factors for poor PBSC mobilization. Thus, alternative strategies of mobilization is needed to reduce risk of poor mobilization in a such group of patient.

Bangladesh Journal of Medical Science Vol.19(3) 2020 p.458-466

Downloads

Download data is not yet available.
Abstract
443
PDF
463

Downloads

Published

2020-03-10

How to Cite

Hassan, M. N., Husin, A., Mustaffa, R., Hassan, R., Ibrahim, M. I., Abdullah, A. D., & Noor, N. H. M. (2020). Risk Factors for PoorAutologous Peripheral blood Stem Cell Mobilization among Lymphoproliferative Disease Patients. Bangladesh Journal of Medical Science, 19(3), 458–466. https://doi.org/10.3329/bjms.v19i3.45863

Issue

Vol. 19 No. 3 (2020)

Section

Original Articles

License

Authors who publish in the Bangladesh Journal of Medical Science agree to the following terms that:

  1. Authors retain copyright and grant Bangladesh Journal of Medical Science the right of first publication of the work.

  2. Creative Commons Licence
    Articles in Bangladesh Journal of Medical Science are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
  3. Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  4. Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.